A complex set of interactions between biological, genetic, and environmental factors likely underlies the development of Alzheimer’s disease (AD). Identifying which of these factors is most associated with AD is important for early diagnosis and treatment.
Objective:
We sought to examine genetic risk and structural brain volume on episodic memory in a sample of older adults ranging from cognitively normal to those diagnosed with AD.
Methods:
686 adults (55–91 years old) completed a 3T MRI scan, baseline cognitive assessments, and biospecimen collection through the Alzheimer’s Disease Neuroimaging Initiative. Hierarchical linear regression analyses examined main and interaction effects of medial temporal lobe (MTL) volume and polygenic hazard score (PHS), indicating genetic risk for AD, on a validated episodic memory composite score.
Results:
Genetic risk moderated the relationship between MTL volume and memory, such that individuals with high PHS and lower hippocampal and entorhinal volume had lower memory composite scores [ΔF (1,677) = 4.057, p = 0.044, ΔR2 = 0.002]. Further analyses showed this effect was driven by the left hippocampus [ΔF(1,677) = 5.256, p = 0.022, ΔR2 = 0.003] and right entorhinal cortex [ΔF (1,677) = 6.078, p = 0.014, ΔR2 = 0.003].
Conclusions:
Among those with high genetic risk for AD, lower volume was associated with poorer memory. Results suggest that the interaction between AD genetic risk and MTL volume increases the likelihood for memory impairment among older adults. Results from this study suggest that genetic risk and brain volume should be considered key factors in tracking cognitive decline.
JackCR, KnopmanDS, JagustWJ, ShawLM, AisenPS, WeinerMW, PetersenRC, TrojanowskiJQ (2010) Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade. Lancet Neurol9, 119–128.
7.
XieL, WisseLEM, PlutaJ, FloresR de, PiskinV, ManjónJV, WangH, DasSR, DingS-L, WolkDA, YushkevichPA (2019) Automated segmentation of medial temporal lobe subregions on in vivo T1-weighted MRI in early stages of Alzheimer’s disease. Hum Brain Mapp40, 3431–3451.
8.
JackCR, PetersenRC, XuY, O’BrienPC, SmithGE, IvnikRJ, TangalosEG, KokmenE (1998) Rate of medial temporal lobe atrophy in typical aging and Alzheimer’s disease. Neurology51, 993–999.
9.
RaslauFD, MarkIT, KleinAP, UlmerJL, MathewsV, MarkLP (2015) Memory Part 2: The role of the medial temporal lobe. Am J Neuroradiol36, 846–849.
10.
GatzM, ReynoldsCA, FratiglioniL, JohanssonB, MortimerJA, BergS, FiskeA, PedersenNL (2006) Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry63, 168–174.
11.
BettensK, SleegersK, Van BroeckhovenC (2013) Genetic insights in Alzheimer’s disease. Lancet Neurol12, 92–104.
12.
CorderEH, SaundersAM, StrittmatterWJ, SchmechelDE, GaskellPC, SmallGW, RosesAD, HainesJL, Pericak-VanceMA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science261, 921–923.
13.
StrittmatterWJ, SaundersAM, SchmechelD, Pericak-VanceM, EnghildJ, SalvesenGS, RosesAD (1993) Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A90, 1977–1981.
14.
LewisCM, VassosE (2017) Prospects for using risk scores in polygenic medicine. Genome Med9, 96.
WangX, ZhouW, YeT, LinX, ZhangJ (2019) The relationship between hippocampal volumes and delayed recall is modified by APOE ɛ4 in mild cognitive impairment. Front Aging Neurosci11, 36.
17.
TulvingE (1972) Episodic and semantic memory. In Organization of memory, Academic Press, Oxford, England, pp. xiii, 423–xiii, 423.
18.
TulvingE (1985) Memory and consciousness. Can Psychol Can26, 1–12.
19.
AlbertMS, DeKoskyST, DicksonD, DuboisB, FeldmanHH, FoxNC, GamstA, HoltzmanDM, JagustWJ, PetersenRC, SnyderPJ, CarrilloMC, ThiesB, PhelpsCH (2011) The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement7, 270–279.
20.
GoldCA, BudsonAE (2008) Memory loss in Alzheimer’s disease: Implications for development of therapeutics. Expert Rev Neurother8, 1879–1891.
21.
CranePK, CarleA, GibbonsLE, InselP, MackinRS, GrossA, JonesRN, MukherjeeS, CurtisSM, HarveyD, WeinerM, MungasD (2012) Development and assessment of a composite score for memory in the Alzheimer’s Disease Neuroimaging Initiative (ADNI). Brain Imaging Behav6, 502–516.
22.
MorrisJC (1993) The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology43, 2412–2414.
23.
ElwoodRW (1991) The Wechsler Memory Scale—Revised: Psychometric characteristics and clinical application. Neuropsychol Rev2, 179–201.
24.
BucknerRL, HeadD, ParkerJ, FotenosAF, MarcusD, MorrisJC, SnyderAZ (2004) A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: Reliability and validation against manual measurement of total intracranial volume. Neuroimage23, 724–738.
HarrisonTM, BookheimerSY (2016) Neuroimaging genetic risk for Alzheimer’s disease in preclinical individuals: From candidate genes to polygenic approaches. Biol Psychiatry Cogn Neurosci Neuroimaging1, 14–23.
28.
DudbridgeF (2013) Power and predictive accuracy of polygenic risk scores. PLoS Genet9, e1003348.
29.
RaghavanN, TostoG (2017) Genetics of Alzheimer’s disease: The importance of polygenic and epistatic components. Curr Neurol Neurosci Rep17, 78.
30.
MaruszakA, ThuretS (2014) Why looking at the whole hippocampus is not enough—a critical role for anteroposterior axis, subfield and activation analyses to enhance predictive value of hippocampal changes for Alzheimer’s disease diagnosis. Front Cell Neurosci8, 95.
31.
MoonSW, LeeB, ChoiYC (2018) Changes in the hippocampal volume and shape in early-onset mild cognitive impairment. Psychiatry Investig15, 531–537.
32.
SteffensDC, PayneME, GreenbergDL, ByrumCE, Welsh-BohmerKA, WagnerHR, MacFallJR (2002) Hippocampal volume and incident dementia in geriatric depression. Am J Geriatr Psychiatry10, 62–71.
